ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids battling leukemia that has come back
Disease control OngoingThis study is testing the safety and best dose of a new three-drug combination for children and young adults whose acute lymphoblastic leukemia (ALL) has returned or not responded to standard treatments. The drugs—ribociclib, everolimus, and dexamethasone—work together to try to …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
New hope for kids with tough cancers: modified transplant aims to stop relapse
Disease control OngoingThis study is for children and young adults (up to age 21) with high-risk blood cancers who need a transplant but lack a perfectly matched donor. It tests a transplant using specially processed blood cells from a partially matched family member. The goal is to see if this modifie…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC